|By JCN Newswire||
|May 27, 2014 02:14 AM EDT||
Tokyo, May 27, 2014 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that it will launch its new carbonated supplement drink Chocola BB Sparkling Salty Natsumikan* Flavor, classified as a Food with Nutrient Function Claims, in Japan on Monday, June 2.
Chocola BB Sparkling Salty Natsumikan Flavor is a new carbonated supplement drink classified by the Japanese Ministry of Health, Labour and Welfare as a Food with Nutrient Function Claims (Niacin). The drink contains five ingredients that help bring out women's beauty from within, including 1,500 mg of vitamin C in addition to niacin, vitamin B1, B6 and iron, and it also contains 56 mg of sodium which becomes increasingly vital for sodium replenishment during summer. It features the clean and refreshing taste of natsumikan, which is popular as a fruit with the image of summer, as well as a low calorie count of just 24 kcal per bottle. As a delicious and easy way to replenish sodium, the drink is designed to address the needs of women who want to stay energetic all summer long.
Chocola BB Sparkling Salty Natsumikan Flavor is the newest member of the Chocola BB Sparkling series including Chocola BB Sparkling Grapefruit & Peach Flavor, Chocola BB Sparkling White Grape Flavor and Chocola BB Sparkling Vitamin Kyutto Lemon Flavor, all of which have been well-received since launch.
Eisai will continue to provide the Chocola BB family of products to respond to the diverse needs of female consumers and support an ever-growing number of people to achieve health and beauty in their everyday lives.
Eisai Co., Ltd. (TSE: 4523; ADR: ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.
Public Relations Department, Eisai Co., Ltd. +81-3-3817-5120
Copyright 2014 JCN Newswire. All rights reserved. www.japancorp.net
Sep. 29, 2016 01:00 AM EDT Reads: 2,298
Sep. 29, 2016 12:15 AM EDT Reads: 482
Sep. 29, 2016 12:00 AM EDT Reads: 2,930
Sep. 28, 2016 11:30 PM EDT Reads: 3,952
Sep. 28, 2016 11:30 PM EDT Reads: 2,727
Sep. 28, 2016 10:30 PM EDT Reads: 3,061
Sep. 28, 2016 09:15 PM EDT Reads: 353
Sep. 28, 2016 08:30 PM EDT Reads: 1,715
Sep. 28, 2016 08:15 PM EDT Reads: 344
Sep. 28, 2016 07:00 PM EDT Reads: 1,628
Sep. 28, 2016 06:45 PM EDT Reads: 4,153
Sep. 28, 2016 06:30 PM EDT Reads: 3,120
Sep. 28, 2016 06:15 PM EDT Reads: 305
Sep. 28, 2016 06:00 PM EDT Reads: 1,777
Businesses are struggling to manage the information flow and interactions between all of these new devices and things jumping on their network, and the apps and IT systems they control. The data businesses gather is only helpful if they can do something with it. In his session at @ThingsExpo, Chris Witeck, Principal Technology Strategist at Citrix, will discuss how different the impact of IoT will be for large businesses, expanding how IoT will allow large organizations to make their legacy ap...
Sep. 28, 2016 05:15 PM EDT Reads: 266